Global Life Sciences Trends and Opportunities 2012-2015

Global Life Sciences Trends and Opportunities 2012-2015

Pharma, Diagnostics, and Research Industry Converge to Address Complex Disease Challenge

RELEASE DATE
13-Dec-2012
REGION
Global
Research Code: NB98-01-00-00-00
SKU: HC02239-GL-MR_07991

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02239-GL-MR_07991

$4,950.00

$3,712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

Frost & Sullivan’s global life sciences team analyzes the impact of important changes and key trends across the total pharmaceutical/biotechnology, diagnostics, and life sciences research industries. This research deliverable captures the global life sciences trends and opportunities for the period of 2012-2015, as supported by Frost & Sullivan’s proprietary research and leading industry experts. Our global life sciences team is uniquely positioned to provide comprehensive analysis and guidance in the converging landscape. Topics include generics and biosimilars, emerging markets, pharmaceutical outsourcing, novel therapeutics, next generation diagnostics, research and development laboratories, and clinical laboratories.

Table of Contents

Introduction

  • Title, Research Team and Contents

Executive Summary

  • Executive Summary

Daunting Challenges for the Pharmaceutical Industry

  • Daunting Challenges

Pharma’s New Growth Strategies

  • Strategies

Curbing the Costs of Drug Development

  • Development

Lean Laboratories—Doing More With Less

  • Lean Laboratories

Novel Biomarker Discovery Leading to Novel Therapeutics

  • Novel Therapeutics

Genetic Technologies are Integral to Healthcare

  • Genetic Technologies are Integral

Conclusions

  • The Last Word

Appendix

  • Additional Information

The Frost & Sullivan Story

  • About Frost & Sullivan
Related Research
Frost & Sullivans global life sciences team analyzes the impact of important changes and key trends across the total pharmaceutical/biotechnology, diagnostics, and life sciences research industries. This research deliverable captures the global life sciences trends and opportunities for the period of 2012-2015, as supported by Frost & Sullivans proprietary research and leading industry experts. Our global life sciences team is uniquely positioned to provide comprehensive analysis and guidance in the converging landscape. Topics include generics and biosimilars, emerging markets, pharmaceutical outsourcing, novel therapeutics, next generation diagnostics, research and development laboratories, and clinical laboratories.
More Information
No Index Yes
Podcast No
Author Winny Tan
Industries Healthcare
WIP Number NB98-01-00-00-00
Is Prebook No